PFIZER
|
|
BOM : 500680     NSE : PFIZER     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Nov 22,2024 |
Price(EOD): ₹ 5,222.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 23,864.77 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
PFIZER | 0.2% | -5.1% | 28.7% |
SUN PHARMACEUTICAL INDUSTRIES | 1.7% | -4.7% | 48.8% |
CIPLA | -0.9% | -1.7% | 17.3% |
DR REDDYS LABORATORIES | -1% | -8.9% | 6.5% |
ZYDUS LIFESCIENCES | -1% | -4% | 48.4% |
DIVIS LABORATORIES | 4.4% | 3.1% | 66% |
MANKIND PHARMA | -2.1% | -0.6% | 33.1% |
TORRENT PHARMACEUTICALS | 2.2% | -5% | 49.1% |
LUPIN | 2.8% | -2.9% | 70.8% |
FUNDAMENTAL ANALYSIS OF PFIZER
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF PFIZER
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
38.66
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 617.90 Cr
[Latest Qtr - Sep2024 - Standalone Results ] 6.64
P/B Calculated based on Book Value of Rs 3,595.54 Cr
[Latest Year - Mar2024 - Standalone Results ] 10.67
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Sep2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
59% 83% 100% |
SHARE PRICE MOMENTUM OF PFIZER
PFIZER vs SENSEX
DEBT OF PFIZER
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF PFIZER
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF PFIZER
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
4.57% 6.63% 6.22% 5.07% |
2.33% 3.64% 7.34% 6.3% |
QtrlyTrend |
8 | |
Latest Qtr: Sep2024 | ||
Quarterly Result Analysis → |
PFIZER related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 400 MIDSMALLCAP | 1.7% | -5.4% | 32.1% |
S&P BSE MIDSMALLCAP | 1.7% | -5% | 34.3% |
S&P BSE 500 | 1.4% | -4.5% | 25.8% |
S&P BSE SMALL CAP | 1.3% | -5.5% | 33.4% |
S&P BSE HEALTHCARE | 1.3% | -2% | 47% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 1.8% | -5.1% | 31.2% |
NIFTY SMALLCAP250 | 1.5% | -5.7% | 30.8% |
NIFTY 500 | 1.4% | -4.5% | 26.3% |
You may also like the below Video Courses
FAQ about PFIZER
Is PFIZER good for long term investment?
As on Nov 22,2024, the Fundamentals of PFIZER look Strong and hence it may be good for long term investment! See Financial Performance of PFIZER . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is PFIZER UnderValued or OverValued?
As on Nov 22,2024, PFIZER is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of PFIZER ?
As on Nov 22,2024, the Intrinsic Value of PFIZER is Rs. 2,846.59 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 3,284.29
Fair Value [Median EV / Sales Model] : Rs. 2,846.59
Fair Value [Median Price / Sales Model] : Rs. 2,607.22
Estimated Median Fair Value of PFIZER : Rs. 2,846.59
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.